Rachel Silva-Smith

Exceptional response to FOLFIRINOX in a patient with pancreatic cancer and a germline RAD51C mutation.

P. Hosein, D. Sussman, S. Palacio, 2018, Journal of gastrointestinal oncology.

Mutation analysis of PALB2 in BRCA1 and BRCA2-negative breast and/or ovarian cancer families from Eastern Ontario, Canada

W. Foulkes, N. Hamel, T. Hartley, 2014, Hereditary cancer in clinical practice.

Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families.

Julie O. Culver, F. Couch, E. Goode, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type

R. Siebert, A. Berchuck, H. Mackay, 2014, Nature Genetics.

Atypical ATMs: Broadening the phenotypic spectrum of ATM-associated hereditary cancer

D. Parekh, D. Sussman, Marilyn Huang, 2023, Frontiers in Oncology.

Co-occurrence of Lynch syndrome and juvenile polyposis syndrome confirmed by multigene panel testing

D. Sussman, Rachel Silva-Smith, 2017, Familial Cancer.

DNA damage repair deficiency as a predictive biomarker for FOLFIRINOX efficacy in metastatic pancreatic cancer.

P. Hosein, T. Donenberg, D. Sussman, 2019, Journal of gastrointestinal oncology.

Application of the ACMG/NSGC genetic referral guidelines for hereditary renal cell carcinoma at the University of Miami, from 2014 to 2017

D. Parekh, S. Blanton, Jessica D. Leuchter, 2021, American journal of medical genetics. Part A.

Primary Peritoneal Carcinoma in a BRCA1/2-negative, PALB2-positive patient

R. Kahn, A. Pinto, S. George, 2016, Gynecologic oncology reports.